Hospira Inc News Headlines

HSP 
$87.54
*  
0.05
0.06%
Get HSP Alerts
*Delayed - data as of Feb. 26, 2015  -  Find a broker to begin trading HSP now
Exchange: NYSE
Industry: Health Care
Community Rating:
View:    HSP After Hours
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save Stocks
Viewing
Filtered By
Ordered By
Parsing the Baker Hughes and Halliburton merger MAC clause
2/26/2015 6:05:00 PM - Market Realist


The Salix–Valeant merger will follow a cash tender timeline
2/26/2015 6:02:00 PM - Market Realist


Basics of the Salix–Valeant merger transaction
2/26/2015 5:06:00 PM - Market Realist


Background of the Baker Hughes and Halliburton merger
2/26/2015 2:06:00 PM - Market Realist


Rationale for the Baker Hughes and Halliburton merger
2/26/2015 10:05:00 AM - Market Realist


Generic Copies of Remicade Go on Sale in Europe
2/25/2015 5:59:00 PM - Dow Jones Business News


Don’t trade the Office Depot spread like a typical arb spread
2/25/2015 4:05:00 PM - Market Realist


Key points of the Baker Hughes and Halliburton merger
2/24/2015 6:05:00 PM - Market Realist


Handicapping the risk-reward balance of the Office Depot deal
2/20/2015 9:05:00 AM - Market Realist


Can Office Depot get antitrust approval?
2/19/2015 3:05:00 PM - Market Realist


Parsing the Office Depot MAC clause, part 2
2/19/2015 11:06:00 AM - Market Realist


The Pharma Revolution That Could Rock Your Portfolio
2/19/2015 7:00:00 AM - Investopedia


This $110 Billion Pharma Revolution Could Make Or Break Your Portfolio
2/19/2015 7:00:00 AM - Investopedia


Parsing the Office Depot Material Adverse Change clause, part 1
2/18/2015 5:05:00 PM - Market Realist


Basics of Staples
2/18/2015 1:06:00 PM - Market Realist


Basics of Office Depot
2/18/2015 9:06:00 AM - Market Realist


Understand the basics of the Staples–Office Depot merger
2/17/2015 11:07:00 AM - Market Realist


Deja vu all over again: Staples and Office Depot attempt a merger
2/16/2015 9:53:00 PM - Market Realist


The punch line: Should you set up the Hospira–Pfizer deal?
2/16/2015 1:05:00 PM - Market Realist


The Hospira–Pfizer merger: Assessing your risks and rewards
2/16/2015 10:06:00 AM - Market Realist


Hospira Launches Biosimilar Inflectra In Major European Markets
2/16/2015 5:13:00 AM - RTT News


Coherus BioSciences: A Sharp Increase, A Sharp Drop, Plus Collateral News Creates A Buying Opportunity
2/14/2015 9:50:00 AM - Seeking Alpha


Could the Hospira–Pfizer deal be thrown by regulatory approvals?
2/13/2015 3:06:00 PM - Market Realist


Parsing the Hospira material adverse change clause, Part II
2/13/2015 1:06:00 PM - Market Realist


Parsing the Hospira material adverse change clause, Part I
2/12/2015 5:06:00 PM - Market Realist